Patents Assigned to EMBRYOGENESIS PTY LTD
  • Publication number: 20210330579
    Abstract: There is provided a formulation for skin rejuvenation comprising lyophilised umbilical cord plasma comprising at least one active chemokine, at least one growth factor and at least one cytokine; a transdermal carrier; and a liposomal base, wherein at least a portion of the lyophilised umbilical cord plasma and transdermal carrier are contained within liposomes of the liposomal base. There is also provided a dosage form for skin rejuvenation comprising 1-5% (w/w) lyophilised umbilical cord plasma comprising at least one active chemokine, at least one growth factor and at least one cytokine; 85-95% (w/w) polyethylene glycol; and 0.1-2% (w/w) gum acacia.
    Type: Application
    Filed: August 1, 2017
    Publication date: October 28, 2021
    Applicant: EMBRYOGENESIS PTY LTD
    Inventors: Peter Britton, Andrew French
  • Publication number: 20210322299
    Abstract: There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 21, 2021
    Applicant: EMBRYOGENESIS PTY LTD
    Inventors: Peter Britton, Andrew French
  • Publication number: 20190183781
    Abstract: There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base.
    Type: Application
    Filed: June 2, 2017
    Publication date: June 20, 2019
    Applicant: EMBRYOGENESIS PTY LTD
    Inventors: Peter Britton, Andrew French